Jang Eun-A, Song Ji-A, Shin Ji Youn, Yoon Jae Joon, Yoo Kyung Yeon, Jeong Seongtae
Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju, 61469, South Korea.
BMC Anesthesiol. 2017 May 30;17(1):73. doi: 10.1186/s12871-017-0364-9.
Administration of arginine vasopressin (AVP) is associated with reducing jugular venous (SjvO) and regional cerebral (rScO) oxygen saturation under propofol-remifentanil (P/R) anaesthesia. We determined whether background anaesthetics modulate the effect of AVP on cerebral oxygenation and haemodynamics.
We randomly allocated 60 adult patients scheduled for shoulder surgery in the beach chair position (BCP) into 4 groups, to receive either an intravenous bolus of saline (groups PR-S and SN-S) or 0.05 U/kg AVP (groups PR-AVP and SN-AVP) under P/R or sevoflurane-nitrous oxide (S/N) anaesthesia (n = 15 each). Haemodynamic variables, SjvO and rScO were measured.
AVP significantly increased mean arterial blood pressure (MAP) and decreased rScO in either anaesthetic group. AVP also decreased SjvO in the P/R groups but not in the S/N groups. The AVP-treated groups showed higher MAP and cerebral desaturation (>20% rScO decrease from baseline), along with lower HR and rScO in the BCP than those in the saline-treated groups. In contrast, AVP did not affect SjvO values or the incidence of SjvO < 50%. Baseline SjvO was lower and the magnitude of its reduction in the BCP was greater in the PR-AVP group than in the SN-AVP group, and the lowest SjvO values were 37 ± 6 and 57 ± 8%, respectively (P < 0.001).
The choice of anaesthetic regimen did not affect cerebral oxygenation or haemodynamics of AVP in the BCP. However, the negative effect of AVP on cerebral oxygenation should be considered, especially under P/R anaesthesia.
ClinicalTrials.gov identifier: NCT01687894 , registered on September 18, 2012.
在丙泊酚-瑞芬太尼(P/R)麻醉下,给予精氨酸加压素(AVP)与降低颈静脉(SjvO)和局部脑(rScO)氧饱和度有关。我们确定了背景麻醉剂是否会调节AVP对脑氧合和血流动力学的影响。
我们将60例计划在沙滩椅位(BCP)进行肩部手术的成年患者随机分为4组,在P/R或七氟醚-氧化亚氮(S/N)麻醉下(每组n = 15),分别接受静脉推注生理盐水(PR-S组和SN-S组)或0.05 U/kg AVP(PR-AVP组和SN-AVP组)。测量血流动力学变量、SjvO和rScO。
在任一麻醉组中,AVP均显著升高平均动脉血压(MAP)并降低rScO。AVP也降低了P/R组的SjvO,但未降低S/N组的SjvO。与生理盐水治疗组相比,接受AVP治疗的组在BCP中显示出更高的MAP和脑去饱和(rScO较基线降低>20%),以及更低的心率和rScO。相比之下,AVP不影响SjvO值或SjvO < 50%的发生率。PR-AVP组的基线SjvO较低,且在BCP中其降低幅度大于SN-AVP组,最低SjvO值分别为37 ± 6%和57 ± 8%(P < 0.001)。
麻醉方案的选择不影响BCP中AVP的脑氧合或血流动力学。然而,应考虑AVP对脑氧合的负面影响,尤其是在P/R麻醉下。
ClinicalTrials.gov标识符:NCT01687894,于2012年9月18日注册。